These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 24508800

  • 1. Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.
    Yamamoto N, Tanida M, Ono Y, Kasahara R, Fujii Y, Ohora K, Suzuki K, Sobue K.
    Biochem Biophys Res Commun; 2014 Feb 28; 445(1):214-7. PubMed ID: 24508800
    [Abstract] [Full Text] [Related]

  • 2. Ketamine reduces amyloid β-protein degradation by suppressing neprilysin expression in primary cultured astrocytes.
    Yamamoto N, Arima H, Naruse K, Kasahara R, Taniura H, Hirate H, Sugiura T, Suzuki K, Sobue K.
    Neurosci Lett; 2013 Jun 17; 545():54-8. PubMed ID: 23624023
    [Abstract] [Full Text] [Related]

  • 3. Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways.
    Yamamoto N, Fujii Y, Kasahara R, Tanida M, Ohora K, Ono Y, Suzuki K, Sobue K.
    Glia; 2016 Jun 17; 64(6):952-62. PubMed ID: 26875818
    [Abstract] [Full Text] [Related]

  • 4. Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways.
    Yamamoto N, Shibata M, Ishikuro R, Tanida M, Taniguchi Y, Ikeda-Matsuo Y, Sobue K.
    Neuroscience; 2017 Oct 24; 362():70-78. PubMed ID: 28844000
    [Abstract] [Full Text] [Related]

  • 5. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N, Ishikuro R, Tanida M, Suzuki K, Ikeda-Matsuo Y, Sobue K.
    Neuroscience; 2018 Aug 10; 385():227-236. PubMed ID: 29932983
    [Abstract] [Full Text] [Related]

  • 6. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM.
    Neurobiol Aging; 2005 May 10; 26(5):645-54. PubMed ID: 15708439
    [Abstract] [Full Text] [Related]

  • 7. Poly(I:C) promotes neurotoxic amyloid β accumulation through reduced degradation by decreasing neprilysin protein levels in astrocytes.
    Yamamoto N, Tokumon T, Obuchi A, Kono M, Saigo K, Tanida M, Ikeda-Matsuo Y, Sobue K.
    J Neurochem; 2022 Dec 10; 163(6):517-530. PubMed ID: 36321194
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y, Hua Q, Lei H, Li P.
    J Ethnopharmacol; 2011 Sep 02; 137(2):1035-46. PubMed ID: 21798326
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH, Lee JK, Choi S, Ahn J, Jin HK, Park JS, Bae JS.
    Brain Res; 2013 Sep 05; 1529():113-24. PubMed ID: 23831521
    [Abstract] [Full Text] [Related]

  • 13. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK, Jha SK, Kumar D, Kejriwal N, Sharma R, Ambasta RK, Kumar P.
    J Alzheimers Dis; 2015 Sep 05; 48(4):891-917. PubMed ID: 26444774
    [Abstract] [Full Text] [Related]

  • 14. Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
    Miners JS, Barua N, Kehoe PG, Gill S, Love S.
    J Neuropathol Exp Neurol; 2011 Nov 05; 70(11):944-59. PubMed ID: 22002425
    [Abstract] [Full Text] [Related]

  • 15. The extracellular signal-regulated kinase cascade suppresses amyloid beta protein-induced promotion of glutamate clearance in cultured rat cortical astrocytes.
    Abe K, Misawa M.
    Brain Res; 2003 Jul 25; 979(1-2):179-87. PubMed ID: 12850584
    [Abstract] [Full Text] [Related]

  • 16. Sevoflurane alters the expression of receptors and enzymes involved in Aβ clearance in rats.
    Liu Y, Gao M, Ma L, Zhang L, Pan N.
    Acta Anaesthesiol Scand; 2013 Aug 25; 57(7):903-10. PubMed ID: 23495897
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
    Li G, Percontino L, Sun Q, Qazi AS, Frederikse PH.
    Mol Vis; 2003 May 01; 9():179-83. PubMed ID: 12740567
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.
    Matos M, Augusto E, Oliveira CR, Agostinho P.
    Neuroscience; 2008 Oct 28; 156(4):898-910. PubMed ID: 18790019
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.